Defining the role of the human intestinal microbiota in childhood asthma and atopic disease
Asthma is a chronic inflammatory atopic disease of the airways affecting one in ten children in Westernized countries. The microflora hypothesis of allergic disease proposes the intestinal microbiota as a potential mechanistic link connecting environmental exposures to changes in the developing immu...
Main Author: | |
---|---|
Language: | English |
Published: |
University of British Columbia
2017
|
Online Access: | http://hdl.handle.net/2429/60117 |
id |
ndltd-UBC-oai-circle.library.ubc.ca-2429-60117 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-UBC-oai-circle.library.ubc.ca-2429-601172018-01-05T17:29:29Z Defining the role of the human intestinal microbiota in childhood asthma and atopic disease Stiemsma, Leah Theresa Asthma is a chronic inflammatory atopic disease of the airways affecting one in ten children in Westernized countries. The microflora hypothesis of allergic disease proposes the intestinal microbiota as a potential mechanistic link connecting environmental exposures to changes in the developing immune system. Further, animal model studies allude to an early life critical window, during which the immune system is most vulnerable to compositional and functional changes in the intestinal microbiota. We conducted an epidemiological assessment of early life environmental factors associated with atopy and wheezing at age 1 year and preschool-age asthma in children enrolled in the Canadian Healthy Infant Longitudinal Development (CHILD) Study (n = 2,695). Here, we identified early life microflora hypothesis related variables (e.g. pre- and post-natal antibiotic exposure, gestational age, and birth mode) as risk and protective factors for asthma and atopic disease. Informed by this epidemiological assessment, we used 16S ribosomal RNA sequencing and quantitative polymerase chain reaction to analyze the 3-month and 1-year fecal microbiota of one-year-old CHILD Study subjects positive or negative for atopy and wheezing (n = 319) and among this same cohort, those who were diagnosed with preschool-age asthma or non-atopic non-wheezing controls (n = 76). The fecal microbiota of atopic wheezing subjects compared to controls showed decreases in the abundances of four gut bacterial genera, Faecalibacterium, Lachnospira, Rothia, and Veillonella, combined with a reduction in fecal acetate at the 3-month time point only. Further, we found shifts in the relative abundances of two bacterial taxa in the 3-month fecal microbiota of preschool-age asthmatic children compared to controls; Lachnospira remained decreased among asthmatic children and Clostridium neonatale was increased in asthmatics. Quartile analysis at 3-months revealed a negative association between the ratio of these two bacteria (Lachnospira/Clostridium neonatale) and asthma risk. Altogether, this research highlights environmental factors that may be contributing to gut bacterial alterations in subjects with asthma or atopic disease. Additionally, these microbial alterations were no longer present by 1-year of age, suggesting the first 100 days of life as the critical window during which taxa-specific gut bacterial dysbiosis is associated with asthma and atopic disease in humans. Science, Faculty of Microbiology and Immunology, Department of Graduate 2017-01-03T16:14:35Z 2017-06-30T00:00:00 2016 2017-02 Text Thesis/Dissertation http://hdl.handle.net/2429/60117 eng Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ University of British Columbia |
collection |
NDLTD |
language |
English |
sources |
NDLTD |
description |
Asthma is a chronic inflammatory atopic disease of the airways affecting one in ten children in Westernized countries. The microflora hypothesis of allergic disease proposes the intestinal microbiota as a potential mechanistic link connecting environmental exposures to changes in the developing immune system. Further, animal model studies allude to an early life critical window, during which the immune system is most vulnerable to compositional and functional changes in the intestinal microbiota.
We conducted an epidemiological assessment of early life environmental factors associated with atopy and wheezing at age 1 year and preschool-age asthma in children enrolled in the Canadian Healthy Infant Longitudinal Development (CHILD) Study (n = 2,695). Here, we identified early life microflora hypothesis related variables (e.g. pre- and post-natal antibiotic exposure, gestational age, and birth mode) as risk and protective factors for asthma and atopic disease.
Informed by this epidemiological assessment, we used 16S ribosomal RNA sequencing and quantitative polymerase chain reaction to analyze the 3-month and 1-year fecal microbiota of one-year-old CHILD Study subjects positive or negative for atopy and wheezing (n = 319) and among this same cohort, those who were diagnosed with preschool-age asthma or non-atopic non-wheezing controls (n = 76). The fecal microbiota of atopic wheezing subjects compared to controls showed decreases in the abundances of four gut bacterial genera, Faecalibacterium, Lachnospira, Rothia, and Veillonella, combined with a reduction in fecal acetate at the 3-month time point only.
Further, we found shifts in the relative abundances of two bacterial taxa in the 3-month fecal microbiota of preschool-age asthmatic children compared to controls; Lachnospira remained decreased among asthmatic children and Clostridium neonatale was increased in asthmatics. Quartile analysis at 3-months revealed a negative association between the ratio of these two bacteria (Lachnospira/Clostridium neonatale) and asthma risk.
Altogether, this research highlights environmental factors that may be contributing to gut bacterial alterations in subjects with asthma or atopic disease. Additionally, these microbial alterations were no longer present by 1-year of age, suggesting the first 100 days of life as the critical window during which taxa-specific gut bacterial dysbiosis is associated with asthma and atopic disease in humans. === Science, Faculty of === Microbiology and Immunology, Department of === Graduate |
author |
Stiemsma, Leah Theresa |
spellingShingle |
Stiemsma, Leah Theresa Defining the role of the human intestinal microbiota in childhood asthma and atopic disease |
author_facet |
Stiemsma, Leah Theresa |
author_sort |
Stiemsma, Leah Theresa |
title |
Defining the role of the human intestinal microbiota in childhood asthma and atopic disease |
title_short |
Defining the role of the human intestinal microbiota in childhood asthma and atopic disease |
title_full |
Defining the role of the human intestinal microbiota in childhood asthma and atopic disease |
title_fullStr |
Defining the role of the human intestinal microbiota in childhood asthma and atopic disease |
title_full_unstemmed |
Defining the role of the human intestinal microbiota in childhood asthma and atopic disease |
title_sort |
defining the role of the human intestinal microbiota in childhood asthma and atopic disease |
publisher |
University of British Columbia |
publishDate |
2017 |
url |
http://hdl.handle.net/2429/60117 |
work_keys_str_mv |
AT stiemsmaleahtheresa definingtheroleofthehumanintestinalmicrobiotainchildhoodasthmaandatopicdisease |
_version_ |
1718585478742016000 |